VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc. (VTGN) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 65 transactions totaling $18.4M, demonstrating a bullish sentiment with $18.1M in net insider flow. The most recent transaction on Dec 31, 2025 involved a transaction of 4,386 shares valued at $2.5K.
VTGN Insider Activity Summary
Who Is Buying VTGN Stock?
No significant insider buying has been recorded for VTGN in the recent period.
Who Is Selling VTGN Stock?
No significant insider selling has been recorded for VTGN in the recent period.
Is VistaGen Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VTGN is bullish with an Insider Alignment Score of 99/100 and a net flow of $18.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VTGN Frequently Asked Questions
Understanding VTGN Insider Activity
Insider trading at VistaGen Therapeutics, Inc. (VTGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading VTGN stock, having executed 65 transactions in the past 90 days. The most active insider is Capital Lp Commodore (Executive), who has made 1 transactions totaling $18.0M.
Related Tools
Track VistaGen Therapeutics, Inc. Insider Activity
Get notified when executives and directors at VTGN file new Form 4 transactions